Atmo Biosciences
Demystifying the Human GutAtmo Biosciences
The Atmo Gas Capsule is a world first patented solution to accurately profile the gases within the gut, leading to better diagnosis and treatment of patients.
Blog Posts
15th October, 2024
Atmo awarded Stage 2 funding through ANDHealth+ program.
14 October 2024. Atmo Biosciences is pleased to announce that it has been awarded funding through th...
2nd May, 2024
Atmo Gas Capsule used in Florida State University study assessing gastrointestinal impact of a fasting diet
May 2, 2024. Clinical Research. Atmo Biosciences’ ingestible gas-sensing capsule was used to assess ...
9th April, 2024
Atmo Biosciences reaches primary endpoints in pivotal clinical study for initial indication
April 9, 2024. Atmo Biosciences is delighted to report that it has successfully reached its primary ...
9th February, 2024
Atmo Gas Capsule hits 1,000 ingestions during clinical trials
February 8, 2024. The Atmo Gas Capsule has been safely ingested more than 1,000 times during formal,...
14th December, 2023
Atmo Biosciences achieves patient recruitment target for dysmotility pivotal clinical study
December 14, 2023. Atmo Biosciences has reached its patient recruitment target ahead of schedule for...
16th November, 2023
Published editorial describes Atmo’s gas-sensing capsule as a “disruptive technology” enabling “step change” in approach to assessing colonic fermentation in IBS patients.
November 16, 2023. An editorial published in the journal Alimentary Pharmacology and Therapeutics de...
12th November, 2023
Atmo Biosciences and RMIT granted Japanese Patent for ingestible gas-sensing capsule
November 13, 2023. Atmo Biosciences is pleased to announce that the Japan Patent Office has granted ...
26th October, 2023
Atmo Biosciences partners with ps.healthcare to expand Machine Learning (ML) and Artificial Intelligence (AI) capabilities
October 26, 2023. Atmo Biosciences today announced it is partnering with ps.healthcare to shape its ...
19th October, 2023
Study indicates Atmo Gas Capsule could be used to evaluate duodeno-gastric reflux in dysmotility patients.
October 19, 2023. The Atmo Gas Capsule could be used to help understand and monitor duodeno-gastric ...
2nd October, 2023
Atmo Biosciences reaches 60 per cent recruitment target in dysmotility pivotal clinical study
October 3, 2023. Atmo Biosciences has reached 60 per cent of its recruitment target for a pivotal cl...